VANTAGE CONSULTING GROUP INC – Royalty Pharma plc Transaction History
VANTAGE CONSULTING GROUP INC portfolio value:
$41.07M
portfolio value
VANTAGE CONSULTING GROUP INC quarter portfolio value change:
-4.42%
quarter
Royalty Pharma plc 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.82% | -29.70K shares | -3.15M | $40.18 | 1.02M |
| Q2 2022 | share | Decrease | -61.44% | -1.67M shares | -62.05M | $42.04 | 1.05M |
| Q1 2022 | share | Decrease | -40.71% | -1.87M shares | -77.07M | $38.96 | 2.72M |
| Q4 2021 | share | Decrease | -41.48% | -3.26M shares | -100.79M | $40.08 | 4.60M |
| Q3 2021 | share | Decrease | -15.48% | -1.43M shares | -97.15M | $35.99 | 7.86M |
| Q2 2021 | share | Increase | +6.86% | 596.89K shares | 1.57M | $40.65 | 9.30M |
| Q1 2021 | share | Decrease | -59.47% | -12.77M shares | -695.20M | $43.07 | 8.70M |
| Q4 2020 | share | Increase | 0.00% | 21.47M shares | 1.07B | $49.24 | 21.47M |